Article
miR‐148a‐3p silences the CANX/MHC‐I pathway and impairs CD8 + T cell‐mediated immune attack in colorectal cancer
29 Jul 2021
Abstract excerpt
Abstract Nonresponse, or acquired resistance to immune checkpoint inhibitors in colorectal cancer (CRC) highlight the importance of finding potential tolerance mechanisms. Low expression of major histocompatibility complex, class I (MHC‐I) on the cell surface of the tumor is one of the main mechanisms of tumor escape from T‐cell recognition and destruction. In this study, we demonstrated that a high level of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
